TY - JOUR
T1 - Pathology definitions and resection strategies for early colorectal neoplasia
T2 - Eastern versus Western approaches in the post-Vienna era
AU - Nishimura, Makoto
AU - Saito, Yutaka
AU - Nakanishi, Yukihiro
AU - Shia, Jinru
AU - Lauwers, Gregory Y.
AU - Wallace, Michael B.
N1 - Funding Information:
DISCLOSURE: The following author disclosed financial relationships: M. Nishimura: Consultant for Boston Scientific; M. Wallace: Consultant for Virgo Inc, Cosmo/Aries Pharmaceuticals, Anx Robotica (2019), and Covidien; research grants from Fujifilm, Boston Scientific, Olympus, Medtronic, Ninepoint Medical, and Cosmo/Aries Pharmaceuticals; stock/stock options from Virgo Inc; consulting on behalf of Mayo Clinic: GI Supply (2018), Endokey, Endostart, and Boston Scientfic; general payments/minor food and beverage, Synergy Pharmaceuticals, Boston Scientific, and Cook Medical. All other authors disclosed no financial relationships.
Publisher Copyright:
© 2020 American Society for Gastrointestinal Endoscopy
PY - 2020/5
Y1 - 2020/5
N2 - There is a well-known discrepancy between East and West classifications of colorectal neoplasm, especially “intramucosal carcinoma,” categorized as subgroup 4.4 in the Vienna classification, usually recognized as high-grade dysplasia in the United States and as carcinoma in situ in Japan. Focusing on management, in the current National Comprehensive Cancer Network algorithm, high-grade dysplasia, carcinoma in situ, and intramucosal carcinoma are managed similarly, whereas submucosal invasion by carcinoma requires en bloc resection. To bridge the differences with regard to these conceptual problems in the definition and management of carcinoma in situ and intramucosal carcinoma, endoscopists and pathologists from Japan and the United States gathered and discussed from their perspectives how to accurately assess specimens of en bloc/piecemeal resection and to effectively predict lymph node metastasis risk.
AB - There is a well-known discrepancy between East and West classifications of colorectal neoplasm, especially “intramucosal carcinoma,” categorized as subgroup 4.4 in the Vienna classification, usually recognized as high-grade dysplasia in the United States and as carcinoma in situ in Japan. Focusing on management, in the current National Comprehensive Cancer Network algorithm, high-grade dysplasia, carcinoma in situ, and intramucosal carcinoma are managed similarly, whereas submucosal invasion by carcinoma requires en bloc resection. To bridge the differences with regard to these conceptual problems in the definition and management of carcinoma in situ and intramucosal carcinoma, endoscopists and pathologists from Japan and the United States gathered and discussed from their perspectives how to accurately assess specimens of en bloc/piecemeal resection and to effectively predict lymph node metastasis risk.
UR - http://www.scopus.com/inward/record.url?scp=85079869561&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079869561&partnerID=8YFLogxK
U2 - 10.1016/j.gie.2019.12.021
DO - 10.1016/j.gie.2019.12.021
M3 - Review article
C2 - 31874160
AN - SCOPUS:85079869561
SN - 0016-5107
VL - 91
SP - 983
EP - 988
JO - Gastrointestinal endoscopy
JF - Gastrointestinal endoscopy
IS - 5
ER -